Cme Group Stock Analysis

CME Stock  USD 215.93  0.33  0.15%   
CME Group is fairly valued with Real Value of 218.31 and Target Price of 224.79. The main objective of CME stock analysis is to determine its intrinsic value, which is an estimate of what CME Group is worth, separate from its market price. There are two main types of CME's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect CME's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of CME's stock to identify patterns and trends that may indicate its future price movements.
The CME stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. CME is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. CME Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and CME's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

CME Stock Analysis Notes

About 90.0% of the company shares are held by institutions such as insurance companies. The book value of CME was currently reported as 74.43. The company recorded earning per share (EPS) of 8.86. CME Group last dividend was issued on the 7th of March 2024. The entity had 5:1 split on the 23rd of July 2012. CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois. CME operates under Financial Data Stock Exchanges classification in the United States and is traded on NASDAQ Exchange. It employs 3480 people. For more info on CME Group please contact Cees Vermaas at 312 930 1000 or go to https://www.cmegroup.com.

CME Quarterly Total Revenue

1.44 Billion

CME Group Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. CME's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding CME Group or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
CME Group has a strong financial position based on the latest SEC filings
Over 90.0% of the company shares are held by institutions such as insurance companies
On 26th of March 2024 CME paid $ 1.15 per share dividend to its current shareholders
Latest headline from finance.yahoo.com: Acquisition by William Shepard of tradable shares of CME at 214.71 subject to Rule 16b-3

CME Group Upcoming and Recent Events

Earnings reports are used by CME to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to CME previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
14th of February 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

CME Largest EPS Surprises

Earnings surprises can significantly impact CME's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2003-07-22
2003-06-300.190.210.0210 
2003-04-22
2003-03-310.130.150.0215 
2004-04-27
2004-03-310.240.270.0312 
View All Earnings Estimates

CME Thematic Classifications

In addition to having CME stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Blockchain Idea
Blockchain
Cross-industry collection of firms that are adopting blockchain technology

CME Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as CME is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CME Group backward and forwards among themselves. CME's institutional investor refers to the entity that pools money to purchase CME's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Fmr Inc2023-12-31
M
Goldman Sachs Group Inc2023-12-31
4.7 M
Norges Bank2023-12-31
4.6 M
Fidelity International Ltd2023-12-31
4.3 M
Ameriprise Financial Inc2023-12-31
4.2 M
Guardcap Asset Management Limited2023-12-31
M
Northern Trust Corp2023-12-31
3.8 M
Vontobel Asset Management Inc2023-12-31
3.7 M
T. Rowe Price Associates, Inc.2023-12-31
3.6 M
Vanguard Group Inc2023-12-31
33.5 M
Blackrock Inc2023-12-31
24 M
Note, although CME's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

CME Market Capitalization

The company currently falls under 'Large-Cap' category with a total capitalization of 77.62 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CME's market, we take the total number of its shares issued and multiply it by CME's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

CME Profitablity

CME's profitability indicators refer to fundamental financial ratios that showcase CME's ability to generate income relative to its revenue or operating costs. If, let's say, CME is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, CME's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of CME's profitability requires more research than a typical breakdown of CME's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 0.58 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.62 %, which entails that for every 100 dollars of revenue, it generated $0.62 of operating income.
Last ReportedProjected for 2024
Return On Capital Employed 0.09  0.17 
Return On Assets 0.02  0.03 
Return On Equity 0.12  0.12 

Management Efficiency

CME Group has Return on Asset of 0.0142 % which means that on every $100 spent on assets, it made $0.0142 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1203 %, implying that it generated $0.1203 on every 100 dollars invested. CME's management efficiency ratios could be used to measure how well CME manages its routine affairs as well as how well it operates its assets and liabilities. At present, CME's Return On Assets are projected to increase slightly based on the last few years of reporting. At present, CME's Non Currrent Assets Other are projected to decrease significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 99.6 B, whereas Other Assets are forecasted to decline to about 127.7 M.
Last ReportedProjected for 2024
Price Book Value Ratio 2.83  3.80 
Enterprise Value Multiple 20.21  14.80 
Price Fair Value 2.83  3.80 
The analysis of CME's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze CME's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of CME Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield
0.0399
Forward Dividend Yield
0.0399
Forward Dividend Rate
8.6
Beta
0.498

Technical Drivers

As of the 28th of March, CME shows the Mean Deviation of 0.7983, downside deviation of 1.2, and Risk Adjusted Performance of 0.0374. CME Group technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have collected data for nineteen technical drivers for CME Group, which can be compared to its rivals. Please confirm CME Group downside deviation, treynor ratio, expected short fall, as well as the relationship between the variance and potential upside to decide if CME Group is priced adequately, providing market reflects its regular price of 215.93 per share. Given that CME has jensen alpha of 0.0236, we suggest you to validate CME Group's prevailing market performance to make sure the company can sustain itself in the future.

CME Group Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. CME middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for CME Group. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

CME Group Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CME insiders, such as employees or executives, is commonly permitted as long as it does not rely on CME's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CME insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

CME Outstanding Bonds

CME issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. CME Group uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most CME bonds can be classified according to their maturity, which is the date when CME Group has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

CME Predictive Daily Indicators

CME intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of CME stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

CME Corporate Filings

F4
27th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
22nd of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
21st of March 2024
Other Reports
ViewVerify
F4
19th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
18th of March 2024
Other Reports
ViewVerify
F5
15th of March 2024
The annual filing required by the Securities and Exchange Commission (SEC) from company insiders or beneficial owners
ViewVerify
F4
8th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
7th of March 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

CME Forecast Models

CME's time-series forecasting models are one of many CME's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CME's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About CME Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how CME prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CME shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as CME. By using and applying CME Stock analysis, traders can create a robust methodology for identifying CME entry and exit points for their positions.
Last ReportedProjected for 2024
Pretax Profit Margin 0.74  0.43 
Operating Profit Margin 0.62  0.42 
Net Profit Margin 0.58  0.31 
Gross Profit Margin 0.81  0.92 

Current CME Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. CME analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. CME analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
224.79Buy17Odds
CME Group current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most CME analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand CME stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of CME Group, talking to its executives and customers, or listening to CME conference calls.
CME Analyst Advice Details

CME Stock Analysis Indicators

CME Group stock analysis indicators help investors evaluate how CME stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading CME shares will generate the highest return on investment. By understating and applying CME stock analysis, traders can identify CME position entry and exit signals to maximize returns.
Begin Period Cash Flow2.7 B
Long Term Debt3.4 B
Common Stock Shares Outstanding359.5 M
Total Stockholder Equity26.7 B
Tax Provision925.4 M
Quarterly Earnings Growth Y O Y0.276
Property Plant And Equipment Net681.5 M
Cash And Short Term InvestmentsB
Cash2.9 B
Accounts Payable90.6 M
Net Debt966.7 M
50 Day M A211.9672
Total Current Liabilities93.4 B
Other Operating Expenses2.1 B
Non Current Assets Total34.8 B
Forward Price Earnings22.5225
Non Currrent Assets Other514.1 M
Stock Based Compensation82.9 M
When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for CME Stock analysis

When running CME's price analysis, check to measure CME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CME is operating at the current time. Most of CME's value examination focuses on studying past and present price action to predict the probability of CME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CME's price. Additionally, you may evaluate how the addition of CME to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Is CME's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CME. If investors know CME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CME listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.276
Dividend Share
4.4
Earnings Share
8.86
Revenue Per Share
15.512
Quarterly Revenue Growth
0.192
The market value of CME Group is measured differently than its book value, which is the value of CME that is recorded on the company's balance sheet. Investors also form their own opinion of CME's value that differs from its market value or its book value, called intrinsic value, which is CME's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CME's market value can be influenced by many factors that don't directly affect CME's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.